Indefinite Delivery Contract 75N93025D00017

Award Date 9/30/25
Last Date to Order 9/29/35
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the American Type Culture Collection (ATCC), a nonprofit biological resource center located in Manassas, Virginia. The contract has a $148,000,000 ceiling value and a period of performance through September 29, 2030. The contract, which was not set aside for any particular business type, is a multiple award IDC for "DIAGNOSTIC TESTING IDIQ" services. Under this IDC, ATCC...
The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million to be delivered through January 2026 in support of the National Institutes of Health's infectious disease research programs. Under the first delivery order valued at $2,500, Atcc...
The Department of Health and Human Services, through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a single-award Indefinite Delivery Contract valued at $146.3 million to the American Type Culture Collection (ATCC), a nonprofit organization, to provide a range of preclinical infectious disease models and specialized reagents. The contract aims to support the development, refinement, and utilization of animal and animal replacement models to evaluate candidate medical...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to the American Type Culture Collection to provide a quality-assured central repository for the acquisition, authentication, storage, inventory, and distribution of a broad range of biological materials. The contract has a potential value of $545,452,906 over a seven year ordering period ending August 2028. Under the contract, two delivery orders have been...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a multiple award indefinite delivery contract to the American Type Culture Collection for in vitro assessments of antimicrobial activity and related biological products and services. The master contract has a potential value of $30 million over its period of performance from January 2019 to January 2026. Two task orders have been issued against the contract to date. A $3.08 million order was awarded...
The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million and period of performance through January 2026. ATCC received a $2,500 delivery order against this master contract for assessments to take place at...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to American Type Culture Collection to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. With a potential value of $30 million and a period of performance from January 2023 through September 2030, the contract enables task orders to be issued across five areas: product...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The contract W911QY18D0010 is an Indefinite Delivery Contract (IDC) awarded by the U.S. Army's Research, Development and Engineering Command (RDECOM) to the American Type Culture Collection (ATCC), a nonprofit biological resource organization. The contract is part of the Joint Enterprise Research, Development, Acquisition and Production/Procurement (JE-RDAP) program, with a ceiling value of $8,276,161,000. The contract aims to provide centralized biological resource repositories and...

This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to American Type Culture Collection (ATCC), a nonprofit biological resource center. The contract has a ceiling value of $136,588,701.00 and a period of performance through September 29, 2035.

The purpose of this IDC is to provide evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases. ATCC, as the prime contractor, will leverage its expertise in collecting, authenticating, producing, preserving, and distributing standard reference microorganisms and other research-critical biological resources to support NIAID's research, medical countermeasure development, and pandemic preparedness efforts. The contracted services may include pathogen growth and storage, biospecimen processing, viral stock preparation, large-scale biomaterial manufacturing, and production of well-characterized challenge materials for infectious disease research. ATCC has a proven track record of successfully competing for and executing similar federal contracts and grants across multiple agencies, including the Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Defense.

Generated 10/1/25, 9:58 AM